Fetal Exposure to Tobacco and Cannabis

Author(s):  
Edore C. Onigu-Otite

Tobacco and cannabis are the most commonly used legal and illegal substances among pregnant women in the United States, respectively. About 12% to 25% of women smoke tobacco during pregnancy. Smoking tobacco during pregnancy and maternal exposure to environmental tobacco smoke during pregnancy is associated with a variety of adverse fetal outcomes. About 11% of women of childbearing age reported using cannabis in the preceding month. Fetal exposure to tobacco or cannabis is associated with dysregulation in development and may indicate a higher risk for neurodevelopmental and other psychiatric problems. As research has become more sophisticated, findings suggest that some of the associations between fetal exposure to cannabis and tobacco and adverse outcomes may be due to familial genetic risk factors. Separating environmental, familial, and genetic factors while disentangling their interactive effects on fetal and offspring development and neurobehavioral regulation remains a challenge in this field of study.

2010 ◽  
Vol 202 (5) ◽  
pp. 436.e1-436.e8 ◽  
Author(s):  
Adit A. Ginde ◽  
Ashley F. Sullivan ◽  
Jonathan M. Mansbach ◽  
Carlos A. Camargo

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Kalpana Betha ◽  
Jamie M. Robertson ◽  
Gong Tang ◽  
Catherine L. Haggerty

Background. Infection withChlamydia trachomatis(CT) can lead to reproductive sequelae. Information on the general population of childbearing age women in India is sparse. We reviewed the literature on CT prevalence within the general population of reproductive aged women in order to improve the efforts of public health screening programs and interventions.Objective. To conduct a literature review to determine the prevalence ofChlamydia trachomatisamong childbearing age women in India.Search Strategy. Ovid Medline and PubMed databases were searched for articles from January 1, 2003, through December 31, 2014. Search terms included “Chlamydia trachomatis”, “CT”, “prevalence”, “India”, and “sexually transmitted infections”.Selection Criteria. Studies on prevalence data for CT among women of childbearing age (15–45) living in India were included.Data Collection and Analysis. Articles that met the inclusion criteria were extracted by two readers and discrepancies solved through discussion.Results. Reported prevalence of active CT infection among lower risk groups ranged from 0.1% to 1.1% and in higher risk group from 2.7% to 28.5%.Conclusion.CT prevalence among women in India is comparable to other countries. Screening programs to prevent adverse outcomes among Indian women of childbearing age and their offspring are warranted.


Sign in / Sign up

Export Citation Format

Share Document